SCHEMBL20156007

SCHEMBL20156007

CCOC(=O)/C(C=N)=C/NCCc1ccc2cccnc2n1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
CYP2C19 P33261 1/20 0.40
SUCNR1 Q9BXA5 11/20 0.38
ALDH1A1 P00352 1/20 0.35
OXGR1 Q96P68 2/20 0.35
PDE10A Q9Y233 3/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
BDKRB1 P46663 1/20 0.34
GRM4 Q14833 1/20 0.34
CTDSP1 Q9GZU7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20156289 0.94 SUCNR1 (0.41) CYP1A2CYP3A4CYP2D6MAPTMAPK1
SCHEMBL20156292 0.86 MAPT (0.39) CYP1A2CYP3A4CYP2D6MAPTMAPK1
SCHEMBL20156243 0.83 MAPT (0.41) CYP1A2CYP3A4CYP2D6MAPTMAPK1
SCHEMBL23912916 0.80 MAPT (0.40) CYP1A2CYP3A4CYP2D6MAPTMAPK1
SCHEMBL20156254 0.78 SUCNR1 (0.39) SUCNR1ALDH1A1OXGR1PDE10AMEN1
SCHEMBL20156039 0.76 SUCNR1 (0.38) CYP1A2CYP3A4CYP2D6MAPTMAPK1
SCHEMBL20156009 0.75 CXCR4 (0.47)
SCHEMBL20156362 0.75 CYP1A2 (0.39) CYP1A2CYP3A4CYP2D6MAPTMAPK1
SCHEMBL20156307 0.74 SUCNR1 (0.40) SUCNR1ALDH1A1OXGR1PDE10AMEN1
SCHEMBL20156316 0.74 SUCNR1 (0.39) SUCNR1ALDH1A1OXGR1PDE10AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538527-B1 AZOLE AMIDES AND AMINES AS ALPHA V INTEGRIN INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2021-10-13 EP disclosed
WO-2018089358-A1 AZOLE AMIDES AND AMINES AS ALPHA V INTEGRIN INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-17 WO disclosed